Critical IllnessNCT04045210
Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function
A study testing Psychological Support Based on Positive Suggestions in people with Critical Illness, run by Mayo Clinic at 1 site in United States.
Trial summary
The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to… Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Critical Illness
- What is being tested?
- Psychological Support Based on Positive Suggestions
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 274 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Aug 2019to 15 Mar 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Critically ill adult patients (age >18) requiring non-invasive ventilation, high flow O2 or mechanical ventilation and expected to stay >48 hours.
Who cannot join
- history of dementia
- intellectual disability
- suicide attempt
- psychotic disorders such as schizophrenia
- acute alcohol/substance intoxication or withdrawal
- severe metabolic encephalopathy
Show all 9Show fewer
- patients on comfort care
- Patients not expected to survive the hospital stay
- Non-English speaking.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Randomized Controlled Trial to Evaluate Efficacy of Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function
The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to them.
Read the detailed description
Background:
Psychological morbidity is a major health problem among survivors of critical illness, with no effective intervention available to mitigate its burden. Advances in intensive care have increased survival to hospital discharge, but resolution of critical illness does not end a patient's struggles. New or worsening physical, cognitive, or mental health impairments may persist for years after an ICU stay and are collectively termed post-intensive care syndrome (PICS). These impairments are associated with rehospitalization, increased health care costs, reduced quality of life, and inability to return to work. Although physical rehabilitation, delirium prevention, and cognitive outcomes have received substantial attention, prevention of mental health morbidity remains largely unaddressed.
More than one-third of critical illness survivors report symptoms of anxiety, depression, or post-traumatic stress disorder (PTSD) 6 to 12 months after discharge. Rates are even higher among survivors of acute respiratory failure, with up to two-thirds experiencing impairment in at least one psychiatric domain, often in all three, for years. No evidence-based intervention is available to prevent or effectively treat this morbidity. Most recognized risk factors, including female sex, alcohol misuse, unemployment, and premorbid psychopathology, are not modifiable. Among modifiable factors, frightening and delusional memories from the ICU appear to be especially important. Anxiety, depression, and PTSD can be conceptualized partly as disorders of memory content in which the emotional representation of a traumatic event persists beyond its adaptive purpose. Once established, these emotionally charged memories are difficult to treat.
Psychological support may therefore need to begin early in critical illness, before traumatic memories become consolidated. Conventional psychological evaluation and treatment are difficult during an ICU stay, and little is known about psychological dysfunction in this setting. During critical illness, thinking may become literal and unusually sensitive to both direct and implied meanings. Patients may accept suggestions without critical appraisal and use communicated messages to interpret their circumstances.
To address this heightened suggestibility, Dr. Varga and colleagues in Hungary adapted therapeutic suggestion to the ICU setting as psychological support based on positive suggestions (PSBPS). Therapeutic suggestion has been used for more than a century in anesthesia, surgery, palliative care, radiology, chronic pain, somatization disorders, obstetrics, and pediatrics. Critically ill patients may experience panic, loss of control, lack of privacy, painful procedures, and dependence on complex technology. They may perceive staff performing painful interventions as adversaries and may develop learned helplessness because they cannot control basic physiological needs. An effective ICU intervention should therefore include the patient as a valued member of the care team who can assist in recovery and participate in rehabilitation.
Investigators developed specific suggestions that can be used verbatim with mechanically ventilated patients. PSBPS has been associated with earlier ventilator weaning and reduced sedative and analgesic requirements. Subsequent analyses suggested that early positive reframing was the most important component. This is consistent with research showing that fear conditioning may be altered during the initial memory-consolidation window. Mitigating information introduced after memory formation and recall, during the reconsolidation window, may also modify the emotional experience of the memory. Thus, early positive reframing may weaken or prevent traumatic emotional memories by shaping their consolidation and reconsolidation while memories remain labile. For critically ill patients, this approach requires psychological support as soon as feasible after admission and in parallel with medical care.
PSBPS can be delivered regardless of a patient's level of participation and may begin during sedation. Semantic processing can continue during altered states of consciousness, and some patients later recall statements made while they were comatose. These preliminary findings support further evaluation of PSBPS as an early preventive intervention for psychological morbidity after critical illness.
Methods:
Design. This is a two-arm, single-center, prospective, randomized controlled trial comparing PSBPS with no PSBPS in critically ill adults. Trained ICU doulas will administer PSBPS to eligible patients.
Eligible patients will be randomized at the earliest feasible time after meeting inclusion criteria. Randomization will be 1:1 to the intervention or non-intervention arm and stratified by ICU location. Both groups will receive standard medical care at the discretion of the ICU team. The intervention group will receive PSBPS as soon as feasible and daily thereafter. ICU doulas will also liaise with the patient's family, clinical team, and nursing staff.
After ICU discharge and again at 6 months by telephone, participants in both groups will complete questionnaires assessing anxiety, depression, acute stress, and cognitive function. Questionnaire results will not be entered into the medical record. The intervention will occur once daily, and all participants assigned to PSBPS will receive the same intervention. Session duration will depend on the clinical situation. In prior experience, bedside sessions sometimes lasted more than 20 minutes, whereas procedures, tests, or other clinical needs occasionally required shorter sessions.
Retention strategy. Questionnaire length and frequency have been minimized to reduce burden. Additional retention strategies include emphasizing the study's potential benefits, engaging participants as partners with the research team, and using the organized and persistent follow-up processes of the anesthesia clinical research unit. All available telephone numbers will be collected to facilitate follow-up. Participants will receive financial compensation after completing the 6-month questionnaires.
Sample Size and Power
A 2-point difference in the Hospital Anxiety and Depression Scale anxiety subscale (HADS-A) was considered clinically meaningful based on prior studies. In our preliminary study, the mean baseline HADS-A score after ICU discharge was 7.7 (SD 3.9). Assuming a pooled standard deviation of 4.0, 64 participants per arm would provide 80% power to detect a 2-point difference using a two-sided two-sample t-test with α=0.05. To account for anticipated attrition, enrollment was planned until 182 participants (91 per arm) had been randomized and completed the baseline post-ICU discharge HADS-A assessment.
This sample size was expected to provide adequate power to evaluate the prespecified psychological and cognitive outcome measures assessed after ICU discharge and at 6-month follow-up, including symptoms of anxiety, depression, post-traumatic stress, cognitive function, and health-related quality of life. The study was also intended to provide data to inform the design of a future multicenter trial.
Analysis Plan
Demographic characteristics and in-hospital clinical characteristics abstracted from the electronic health record were summarized using descriptive statistics (means, medians, standard deviations, interquartile ranges, counts, and percentages, as appropriate). These variables were used to characterize the study population and, where appropriate, as covariates in adjusted analyses; they were not prespecified efficacy outcome measures.
The effect of the intervention on the prespecified psychological and cognitive outcome measures was estimated using analysis of covariance (ANCOVA) with adjustment for relevant prerandomization characteristics identified in earlier studies. A nonparametric Wilcoxon rank-sum test was planned when appropriate. Interactions with relevant variables, including sex and race/ethnicity, were explored to assess whether intervention effects differed across key subgroups, although the study was not powered for these comparisons.
Missing questionnaire data were anticipated primarily because of inability to complete assessments, death, or loss to follow-up. The primary analysis followed the intent-to-treat principle, with complete-case analyses supplemented by sensitivity analyses using multiple imputation and worst-case imputation where appropriate. Statistical significance was defined as a two-sided p<0.05.
- Conditions
- Critical Illness
- Being tested
- Psychological Support Based on Positive Suggestions
- Medical subject headings
- Critical Illness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychological Support Based on Positive SuggestionsOther
Eligible patients will be randomized at the earliest possible time after meeting inclusion criteria. Patients will be randomized 1:1 to intervention by ICU doulas or a non-intervention arms stratified by ICU location. Both intervention and controls will receive standard medical care at the discretion of the ICU team. The intervention arm will receive PSBPS as soon as feasible and continue on a daily basis. Doulas will also liaise with family, the team, and with the nursing staff. Both intervention and standard of care arms will complete follow-up questionnaires measuring symptoms of anxiety, depression, acute stress and cognitive function after ICU discharge and at 6 months follow up by phone. All the patients randomized to the intervention arm will receive the same intervention.
| Study group | Role | What they receive |
|---|---|---|
| No Intervention | No intervention | Not described |
| Doula | Experimental | Not described Receives: Other: Psychological Support Based on Positive Suggestions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospital Anxiety and Depression Scale - Anxiety
This outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the intervention group within 96 hours after ICU discharge and at 6 months follow up
Measured: within 96 hours after ICU discharge and 6 months after hospital discharge
Secondary outcomes (1)
Hospital Anxiety and Depression Scale-Depression
This outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the intervention group within 96 hours after ICU discharge and at 6 months follow up
Measured: within 96 hours after ICU discharge and 6 months after hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2019
- Study start30 Aug 2019
- Primary completion31 Jan 2025
- Study completion15 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Critical IllnessStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This will be a tho arm single-center, prospective, randomized, controlled trial comparing the effect of PSBPS vs. no PSBPS on psychological and clinical outcomes in the critically ill population. PSBPS will be administered by trained ICU doulas to eligible patients
- Masking
- None (open label)
- Enrolment
- 274 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Responsible party
- Principal investigator, Lioudmila Karnatovskaia, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04045210
- Sponsor's protocol ID
- 19-004660
- Other IDs
- 5K23HL146741
- Status last verified
- Aug 2026
- First submitted
- 25 Jul 2019
- Last updated
- 21 Aug 2026
- Results posted
- Yes, on ClinicalTrials.gov
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Controlled Trial to Evaluate Efficacy of Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function
- ClinicalTrials.gov ID
- NCT04045210
- Acronym / sponsor ID
- 19-004660
- Conditions
- Critical Illness
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 274 participants (actual)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- 30 Aug 2019 (actual)
- Primary completion
- 31 Jan 2025 (actual)
- Study completion
- 15 Mar 2025 (actual)
- First posted
- 5 Aug 2019 (actual)
- Results
- Posted 21 Aug 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to them.
Detailed description
Background:
Psychological morbidity is a major health problem among survivors of critical illness, with no effective intervention available to mitigate its burden. Advances in intensive care have increased survival to hospital discharge, but resolution of critical illness does not end a patient's struggles. New or worsening physical, cognitive, or mental health impairments may persist for years after an ICU stay and are collectively termed post-intensive care syndrome (PICS). These impairments are associated with rehospitalization, increased health care costs, reduced quality of life, and inability to return to work. Although physical rehabilitation, delirium prevention, and cognitive outcomes have received substantial attention, prevention of mental health morbidity remains largely unaddressed.
More than one-third of critical illness survivors report symptoms of anxiety, depression, or post-traumatic stress disorder (PTSD) 6 to 12 months after discharge. Rates are even higher among survivors of acute respiratory failure, with up to two-thirds experiencing impairment in at least one psychiatric domain, often in all three, for years. No evidence-based intervention is available to prevent or effectively treat this morbidity. Most recognized risk factors, including female sex, alcohol misuse, unemployment, and premorbid psychopathology, are not modifiable. Among modifiable factors, frightening and delusional memories from the ICU appear to be especially important. Anxiety, depression, and PTSD can be conceptualized partly as disorders of memory content in which the emotional representation of a traumatic event persists beyond its adaptive purpose. Once established, these emotionally charged memories are difficult to treat.
Psychological support may therefore need to begin early in critical illness, before traumatic memories become consolidated. Conventional psychological evaluation and treatment are difficult during an ICU stay, and little is known about psychological dysfunction in this setting. During critical illness, thinking may become literal and unusually sensitive to both direct and implied meanings. Patients may accept suggestions without critical appraisal and use communicated messages to interpret their circumstances.
To address this heightened suggestibility, Dr. Varga and colleagues in Hungary adapted therapeutic suggestion to the ICU setting as psychological support based on positive suggestions (PSBPS). Therapeutic suggestion has been used for more than a century in anesthesia, surgery, palliative care, radiology, chronic pain, somatization disorders, obstetrics, and pediatrics. Critically ill patients may experience panic, loss of control, lack of privacy, painful procedures, and dependence on complex technology. They may perceive staff performing painful interventions as adversaries and may develop learned helplessness because they cannot control basic physiological needs. An effective ICU intervention should therefore include the patient as a valued member of the care team who can assist in recovery and participate in rehabilitation.
Investigators developed specific suggestions that can be used verbatim with mechanically ventilated patients. PSBPS has been associated with earlier ventilator weaning and reduced sedative and analgesic requirements. Subsequent analyses suggested that early positive reframing was the most important component. This is consistent with research showing that fear conditioning may be altered during the initial memory-consolidation window. Mitigating information introduced after memory formation and recall, during the reconsolidation window, may also modify the emotional experience of the memory. Thus, early positive reframing may weaken or prevent traumatic emotional memories by shaping their consolidation and reconsolidation while memories remain labile. For critically ill patients, this approach requires psychological support as soon as feasible after admission and in parallel with medical care.
PSBPS can be delivered regardless of a patient's level of participation and may begin during sedation. Semantic processing can continue during altered states of consciousness, and some patients later recall statements made while they were comatose. These preliminary findings support further evaluation of PSBPS as an early preventive intervention for psychological morbidity after critical illness.
Methods:
Design. This is a two-arm, single-center, prospective, randomized controlled trial comparing PSBPS with no PSBPS in critically ill adults. Trained ICU doulas will administer PSBPS to eligible patients.
Eligible patients will be randomized at the earliest feasible time after meeting inclusion criteria. Randomization will be 1:1 to the intervention or non-intervention arm and stratified by ICU location. Both groups will receive standard medical care at the discretion of the ICU team. The intervention group will receive PSBPS as soon as feasible and daily thereafter. ICU doulas will also liaise with the patient's family, clinical team, and nursing staff.
After ICU discharge and again at 6 months by telephone, participants in both groups will complete questionnaires assessing anxiety, depression, acute stress, and cognitive function. Questionnaire results will not be entered into the medical record. The intervention will occur once daily, and all participants assigned to PSBPS will receive the same intervention. Session duration will depend on the clinical situation. In prior experience, bedside sessions sometimes lasted more than 20 minutes, whereas procedures, tests, or other clinical needs occasionally required shorter sessions.
Retention strategy. Questionnaire length and frequency have been minimized to reduce burden. Additional retention strategies include emphasizing the study's potential benefits, engaging participants as partners with the research team, and using the organized and persistent follow-up processes of the anesthesia clinical research unit. All available telephone numbers will be collected to facilitate follow-up. Participants will receive financial compensation after completing the 6-month questionnaires.
Sample Size and Power
A 2-point difference in the Hospital Anxiety and Depression Scale anxiety subscale (HADS-A) was considered clinically meaningful based on prior studies. In our preliminary study, the mean baseline HADS-A score after ICU discharge was 7.7 (SD 3.9). Assuming a pooled standard deviation of 4.0, 64 participants per arm would provide 80% power to detect a 2-point difference using a two-sided two-sample t-test with α=0.05. To account for anticipated attrition, enrollment was planned until 182 participants (91 per arm) had been randomized and completed the baseline post-ICU discharge HADS-A assessment.
This sample size was expected to provide adequate power to evaluate the prespecified psychological and cognitive outcome measures assessed after ICU discharge and at 6-month follow-up, including symptoms of anxiety, depression, post-traumatic stress, cognitive function, and health-related quality of life. The study was also intended to provide data to inform the design of a future multicenter trial.
Analysis Plan
Demographic characteristics and in-hospital clinical characteristics abstracted from the electronic health record were summarized using descriptive statistics (means, medians, standard deviations, interquartile ranges, counts, and percentages, as appropriate). These variables were used to characterize the study population and, where appropriate, as covariates in adjusted analyses; they were not prespecified efficacy outcome measures.
The effect of the intervention on the prespecified psychological and cognitive outcome measures was estimated using analysis of covariance (ANCOVA) with adjustment for relevant prerandomization characteristics identified in earlier studies. A nonparametric Wilcoxon rank-sum test was planned when appropriate. Interactions with relevant variables, including sex and race/ethnicity, were explored to assess whether intervention effects differed across key subgroups, although the study was not powered for these comparisons.
Missing questionnaire data were anticipated primarily because of inability to complete assessments, death, or loss to follow-up. The primary analysis followed the intent-to-treat principle, with complete-case analyses supplemented by sensitivity analyses using multiple imputation and worst-case imputation where appropriate. Statistical significance was defined as a two-sided p<0.05.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This will be a tho arm single-center, prospective, randomized, controlled trial comparing the effect of PSBPS vs. no PSBPS on psychological and clinical outcomes in the critically ill population. PSBPS will be administered by trained ICU doulas to eligible patients
| Arm | Type | Receives |
|---|---|---|
| No Intervention | No intervention | – |
| Doula | Experimental | Other: Psychological Support Based on Positive Suggestions |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Critically ill adult patients (age >18) requiring non-invasive ventilation, high flow O2 or mechanical ventilation and expected to stay >48 hours.
Key exclusion criteria (9 listed)
- history of dementia
- intellectual disability
- suicide attempt
- psychotic disorders such as schizophrenia
- acute alcohol/substance intoxication or withdrawal
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychological Support Based on Positive SuggestionsEligible patients will be randomized at the earliest possible time after meeting inclusion criteria. Patients will be randomized 1:1 to intervention by ICU doulas or a non-intervention arms stratified by ICU location. Both intervention and controls will receive standard medical care at the discretion of the ICU team. The intervention arm will receive PSBPS as soon as feasible and continue on a daily basis. Doulas will also liaise with family, the team, and with the nursing staff. Both intervention and standard of care arms will complete follow-up questionnaires measuring symptoms of anxiety, depression, acute stress and cognitive function after ICU discharge and at 6 months follow up by phone. All the patients randomized to the intervention arm will receive the same intervention. | Other | Doula |
Primary outcome
Hospital Anxiety and Depression Scale - Anxiety
Time frame: within 96 hours after ICU discharge and 6 months after hospital discharge
This outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the intervention group within 96 hours after ICU discharge and at 6 months follow up
1 secondary outcome
Hospital Anxiety and Depression Scale-Depression
Time frame: within 96 hours after ICU discharge and 6 months after hospital discharge
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Critical Illness
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Active, not recruiting
Weighted Blankets for Agitation in Adults in the Intensive Care Unit
Psychomotor Agitation, Critical Illness
Not yet recruitingObservational study
Core Competencies in General Intensive Care Ultrasound (GenIUS): a Delphi Study
Critical Illness, Ultrasound
RecruitingObservational study
Predicting Extubation Failure Using Machine Learning
Extubation Failure, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychological Support Based on Positive Suggestions in people with Critical Illness, run by Mayo Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 21 Aug 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hospital Anxiety and Depression Scale - Anxiety (time frame: within 96 hours after ICU discharge and 6 months after hospital discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.